PPD

6K posts

PPD banner
PPD

PPD

@PPDCRO

As a global provider of clinical development and laboratory services, we improve health by helping customers deliver life-changing therapies.

Global Katılım Temmuz 2010
322 Takip Edilen11.1K Takipçiler
PPD
PPD@PPDCRO·
To help #drugdevelopers address bottlenecks and meet timelines, our FSP solutions provide recruiting & talent development expertise to deliver the best: highly trained, top-tier experts who bring a customer-first, problem-solving mindset. Here’s how. » bit.ly/3RruziX
PPD tweet media
English
0
3
5
1.1K
PPD
PPD@PPDCRO·
In a new article for @Clin_Trials, Sandra Orset reviews trends in audit findings specific to DCTs and provides guidance on how to develop a new project delivery framework that will support audit readiness by focusing on decentralized solutions. » bit.ly/3NbUuJ5
PPD tweet media
English
0
2
7
643
PPD
PPD@PPDCRO·
Meet Sarah Frost, a #medicalwriting expert focused on writing for regulatory agencies, from IND through marketing authorization applications. Our team is committed to providing robust solutions that proactively meet our clients' submission timelines. » bit.ly/3GrQbWq
PPD tweet media
English
0
2
1
491
PPD
PPD@PPDCRO·
Why is it difficult to find the correct treatment for rare diseases? What are the unique challenges for designing & executing rare disease #clinicaltrials? Galina Nesterova & Susan McCune answer these #raredisease questions + more for @OutsourcPharma. » bit.ly/480rWKJ
PPD tweet media
English
0
1
0
246
PPD
PPD@PPDCRO·
The priority of our #medicalinformation contact center team is to utilize our industry insights and expertise to connect patients, caregivers and health care providers to accurate and meaningful information with compassion and support. Learn more. » bit.ly/3R4hrPC
English
0
1
1
273
PPD
PPD@PPDCRO·
📣 #WVCWC: Stop by booth 510 to meet our expert team. Plus, hear Tina Morgenstein speak on the importance of partnership in #vaccine #clinicaltrials.
PPD tweet media
English
0
1
0
249
PPD
PPD@PPDCRO·
#Psoriasis studies typically have a shorter cycle time and require efficient solutions to drive on-time delivery. Learn more about our involvement in the rapid startup of a Phase II psoriasis #clinicaltrial with 50 global research sites. » bit.ly/3N3m2jG
PPD tweet media
English
0
1
0
223
PPD
PPD@PPDCRO·
Maximize drug development efficiency with hybrid outsourcing strategies in clinical trials. Combining full-service outsourcing (FSO) and functional service partnership (FSP) models enhances flexibility and efficiency, driving on-time program delivery. » bit.ly/3uFEetg
PPD tweet media
English
0
1
0
208
PPD
PPD@PPDCRO·
Meet Amy Franklin, whose emphasis on bringing value to clients is a career focus. She explores the FSP #clinicalstudy feasibility offering, which increases the likelihood of enrolling #clinicaltrials on time, within budget and with high quality. » bit.ly/3MNvzeu
PPD tweet media
English
0
1
1
269
PPD
PPD@PPDCRO·
Accessing difficult-to-find #realworlddata. Integrating multiple data sources. Today’s #clinicalresearch data landscape is nothing short of complex. That’s why you need a CRO partner with more than innovative data solutions. Ready to do data different? bit.ly/3sj4sAT
PPD tweet media
English
0
1
0
214
PPD
PPD@PPDCRO·
We surveyed 100 professionals in the #raredisease sector who are working in collaboration with a contract research organization (#CRO). Uncover key insights into rare disease #clinicaltrials, including use of external or synthetic control arms. » bit.ly/3Lg6J6u
PPD tweet media
English
0
1
2
247
PPD
PPD@PPDCRO·
Our unique combination of global site locations and patient-centric, digital solutions take patient engagement, enrollment and retention to a new level. Discover site selection and patient recruitment solutions that center the individual. » bit.ly/3OGQvUF
PPD tweet media
English
0
1
2
170
PPD
PPD@PPDCRO·
Sudhakar Sridharan outlines primary endpoints in #lupus #clinicaltrials and explains how we can expand options for patients with new #clinicalstudy endpoints and innovative therapies. Listen in to the full discussion in our podcast. » bit.ly/40IihWI
English
0
1
2
193